{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T18:12:28Z","timestamp":1695233548507},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Human Papillomavirus (HPV) high-risk (HR) types are the causal factor for cervical cancer and premalignant dysplasia. Data on frequency of HPV types provide a basis to design and evaluate HPV prevention programs. Taking into account the heterogeneity of HPV types across and within populations this study aims to access the HPV frequency in Brazilian women.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified 24 different types of HPV, including a <jats:italic>Betapapillomavirus<\/jats:italic> and a likely new type, previously reported, from 132 women positive for the virus analysed by Hybrid Capture II assay. These women were infected by a single or multiple HPV types and 142 HPV strains were identified. HR types were found in 75% of women and HPV types 16, 18, 45, 58, and 66 had the highest frequency. Significant differences in frequency of HR HPV types were found for presence of cervical lesions, and for different HPV species and women age.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Compared with previous studies in Brazil, our data indicated differences in frequency and HPV type diversity, a significant association of other HR-types but HPV16 and 18 and cervical lesions, and a trend for distinct distribution of HPV types by age.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-422x-8-4","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T20:05:31Z","timestamp":1294257931000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Human Papillomavirus in Brazilian women with and without cervical lesions"],"prefix":"10.1186","volume":"8","author":[{"given":"Michelle","family":"Oliveira-Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila X","family":"Lordello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00edlia MG","family":"Zardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cibele R","family":"Bonvicino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel AM","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,5]]},"reference":[{"key":"1121_CR1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127: 2893-2917. 10.1002\/ijc.25516","journal-title":"Int J Cancer"},{"key":"1121_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55: 244-265.","journal-title":"J Clin Pathol"},{"key":"1121_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2: 342-350. 10.1038\/nrc798","journal-title":"Nat Rev Cancer"},{"key":"1121_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189: 12-19. 10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","journal-title":"J Pathol"},{"key":"1121_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348: 518-527.","journal-title":"N Engl J Med"},{"key":"1121_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007, 121: 621-632. 10.1002\/ijc.22527","journal-title":"Int J Cancer"},{"key":"1121_CR7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","volume":"366","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, et al.: Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366: 991-998. 10.1016\/S0140-6736(05)67069-9","journal-title":"Lancet"},{"key":"1121_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S de Sanjose","year":"2007","unstructured":"de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7: 453-459. 10.1016\/S1473-3099(07)70158-5","journal-title":"Lancet Infect Dis"},{"key":"1121_CR9","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","volume":"364","author":"DM Harper","year":"2004","unstructured":"Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, et al.: Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004, 364: 1757-1765. 10.1016\/S0140-6736(04)17398-4","journal-title":"Lancet"},{"key":"1121_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","volume":"6","author":"LL Villa","year":"2005","unstructured":"Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, et al.: Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005, 6: 271-278. 10.1016\/S1470-2045(05)70101-7","journal-title":"Lancet Oncol"},{"key":"1121_CR11","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(01)06523-0","volume":"358","author":"X Castellsague","year":"2001","unstructured":"Castellsague X, Menendez C, Loscertales MP, Kornegay JR, dos Santos F, Gomez-Olive FX, Lloveras B, Abarca N, Vaz N, Barreto A, et al.: Human papillomavirus genotypes in rural Mozambique. Lancet 2001, 358: 1429-1430. 10.1016\/S0140-6736(01)06523-0","journal-title":"Lancet"},{"key":"1121_CR12","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1099\/vir.0.80001-0","volume":"85","author":"P Naucler","year":"2004","unstructured":"Naucler P, Da Costa FM, Ljungberg O, Bugalho A, Dillner J: Human papillomavirus genotypes in cervical cancers in Mozambique. J Gen Virol 2004, 85: 2189-2190. 10.1099\/vir.0.80001-0","journal-title":"J Gen Virol"},{"key":"1121_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1525-1438.2007.00959.x","volume":"18","author":"YP Bao","year":"2008","unstructured":"Bao YP, Li N, Smith JS, Qiao YL: Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 2008, 18: 71-79. 10.1111\/j.1525-1438.2007.00959.x","journal-title":"Int J Gynecol Cancer"},{"key":"1121_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1590\/S0074-02762003000700003","volume":"98","author":"GN Camara","year":"2003","unstructured":"Camara GN, Cerqueira DM, Oliveira AP, Silva EO, Carvalho LG, Martins CR: Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. Mem Inst Oswaldo Cruz 2003, 98: 879-883. 10.1590\/S0074-02762003000700003","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1121_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1258\/ijsa.2009.008436","volume":"21","author":"SA Lippman","year":"2010","unstructured":"Lippman SA, Sucupira MC, Jones HE, Luppi CG, Palefsky J, van de Wijgert JH, Oliveira RL, Diaz RS: Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. Int J STD AIDS 2010, 21: 105-109. 10.1258\/ijsa.2009.008436","journal-title":"Int J STD AIDS"},{"key":"1121_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1756-0500-3-96","volume":"3","author":"JV Fernandes","year":"2010","unstructured":"Fernandes JV, Meissner RV, Carvalho MG, Fernandes TA, Azevedo PR, Sobrinho JS, Prado JC, Villa LL: Prevalence of human papillomavirus in archival samples obtained from patients with cervical pre-malignant and malignant lesions from Northeast Brazil. BMC Res Notes 2010, 3: 96. 10.1186\/1756-0500-3-96","journal-title":"BMC Res Notes"},{"key":"1121_CR17","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/jmv.21410","volume":"81","author":"S Paesi","year":"2009","unstructured":"Paesi S, Serafini EP, Barea F, Madi SR, Echeverrigaray S: High prevalence of human papillomavirus type 58 in patients with cervical pre-malignant lesions in southern Brazil. J Med Virol 2009, 81: 1270-1275. 10.1002\/jmv.21410","journal-title":"J Med Virol"},{"key":"1121_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1590\/S0074-02762003000200003","volume":"98","author":"SH Rabelo-Santos","year":"2003","unstructured":"Rabelo-Santos SH, Zeferino L, Villa LL, Sobrinho JP, Amaral RG, Magalhaes AV: Human papillomavirus prevalence among women with cervical intraepithelial neoplasia III and invasive cervical cancer from Goiania, Brazil. Mem Inst Oswaldo Cruz 2003, 98: 181-184. 10.1590\/S0074-02762003000200003","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1121_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1590\/S0037-86822010000100002","volume":"43","author":"LH Oliveira","year":"2010","unstructured":"Oliveira LH, Ferreira MD, Augusto EF, Melgaco FG, Santos LS, Cavalcanti SM, Rosa ML: Human papillomavirus genotypes in asymptomatic young women from public schools in Rio de Janeiro, Brazil. Rev Soc Bras Med Trop 2010, 43: 4-8.","journal-title":"Rev Soc Bras Med Trop"},{"key":"1121_CR20","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.4238\/vol8-4gmr677","volume":"8","author":"MF Baldez da Silva","year":"2009","unstructured":"Baldez da Silva MF, Chagas BS, Guimaraes V, Katz LM, Felix PM, Miranda PM, Lima AA, Arraes LC, Martins DB, Lima Filho JL, et al.: HPV31 and HPV33 incidence in cervical samples from women in Recife, Brazil. Genet Mol Res 2009, 8: 1437-1443. 10.4238\/vol8-4gmr677","journal-title":"Genet Mol Res"},{"key":"1121_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/infdis\/172.3.756","volume":"172","author":"EL Franco","year":"1995","unstructured":"Franco EL, Villa LL, Ruiz A, Costa MC: Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J Infect Dis 1995, 172: 756-763.","journal-title":"J Infect Dis"},{"key":"1121_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1046\/j.1525-1438.2000.00007.x","volume":"10","author":"F Lorenzato","year":"2000","unstructured":"Lorenzato F, Ho L, Terry G, Singer A, Santos LC, De Lucena Batista R, Lubambo T: The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil). Int J Gynecol Cancer 2000, 10: 143-150. 10.1046\/j.1525-1438.2000.00007.x","journal-title":"Int J Gynecol Cancer"},{"key":"1121_CR23","doi-asserted-by":"publisher","first-page":"617 e611","DOI":"10.1016\/j.ajog.2008.06.033","volume":"199","author":"MI Rosa","year":"2008","unstructured":"Rosa MI, Fachel JM, Rosa DD, Medeiros LR, Igansi CN, Bozzetti MC: Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am J Obstet Gynecol 2008, 199: 617 e611-617. 10.1016\/j.ajog.2008.06.033","journal-title":"Am J Obstet Gynecol"},{"key":"1121_CR24","first-page":"175","volume":"35","author":"WM Krambeck","year":"2008","unstructured":"Krambeck WM, Cadide RM, Dalmarco EM, de Cordova CM: HPV detection and genotyping as an earlier approach in cervical cancer screening of the female genital tract. Clin Exp Obstet Gynecol 2008, 35: 175-178.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"1121_CR25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1590\/S0034-89102010000500023","volume":"44","author":"AR Ayres","year":"2010","unstructured":"Ayres AR, Azevedo e Silva G: Cervical HPV infection in Brazil: systematic review. Rev Saude Publica 2010, 44: 963-974.","journal-title":"Rev Saude Publica"},{"key":"1121_CR26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/JCM.38.2.651-655.2000","volume":"38","author":"SD Vernon","year":"2000","unstructured":"Vernon SD, Unger ER, Williams D: Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 2000, 38: 651-655.","journal-title":"J Clin Microbiol"},{"key":"1121_CR27","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1086\/382896","volume":"189","author":"T Asato","year":"2004","unstructured":"Asato T, Maehama T, Nagai Y, Kanazawa K, Uezato H, Kariya K: A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis 2004, 189: 1829-1832. 10.1086\/382896","journal-title":"J Infect Dis"},{"key":"1121_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6890-9-3","volume":"9","author":"SH Lee","year":"2009","unstructured":"Lee SH, Vigliotti VS, Vigliotti JS, Pappu S: Validation of human papillomavirus genotyping by signature DNA sequence analysis. BMC Clin Pathol 2009, 9: 3. 10.1186\/1472-6890-9-3","journal-title":"BMC Clin Pathol"},{"key":"1121_CR29","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s10552-009-9365-4","volume":"20","author":"RA Moore","year":"2009","unstructured":"Moore RA, Ogilvie G, Fornika D, Moravan V, Brisson M, Amirabbasi-Beik M, Kollar A, Burgess T, Hsu R, Towers L, et al.: Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination. Cancer Causes Control 2009, 20: 1387-1396. 10.1007\/s10552-009-9365-4","journal-title":"Cancer Causes Control"},{"key":"1121_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1743-422X-7-65","volume":"7","author":"K Zandi","year":"2010","unstructured":"Zandi K, Eghbali SS, Hamkar R, Ahmadi S, Ramedani E, Deilami I, Nejad HA, Farshadpour F, Rastian Z: Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009. Virol J 2010, 7: 65. 10.1186\/1743-422X-7-65","journal-title":"Virol J"},{"key":"1121_CR31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/dc.20699","volume":"35","author":"VR Girianelli","year":"2007","unstructured":"Girianelli VR, Santos Thuler LC: Evaluation of agreement between conventional and liquid-based cytology in cervical cancer early detection based on analysis of 2,091 smears: experience at the Brazilian National Cancer Institute. Diagn Cytopathol 2007, 35: 545-549. 10.1002\/dc.20699","journal-title":"Diagn Cytopathol"},{"key":"1121_CR32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/01.cej.0000220630.08352.7a","volume":"15","author":"VR Girianelli","year":"2006","unstructured":"Girianelli VR, Thuler LC, Szklo M, Donato A, Zardo LM, Lozana JA, Almeida Neto OF, Carvalho AC, Matos JH, Figueiredo V: Comparison of human papillomavirus DNA tests, liquid-based cytology and conventional cytology for the early detection of cervix uteri cancer. Eur J Cancer Prev 2006, 15: 504-510. 10.1097\/01.cej.0000220630.08352.7a","journal-title":"Eur J Cancer Prev"},{"key":"1121_CR33","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1590\/S0034-89102009005000043","volume":"43","author":"VR Girianelli","year":"2009","unstructured":"Girianelli VR, Thuler LC, Silva GA: Quality of cervical cancer data system in the state of Rio de Janeiro, Southeastern Brazil. Rev Saude Publica 2009, 43: 580-588. 10.1590\/S0034-89102009005000043","journal-title":"Rev Saude Publica"},{"key":"1121_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-0201-8","volume-title":"The Bethesda System for reporting cervical\/vaginal cytologic diagnoses","author":"RJ Kurman","year":"1994","unstructured":"Kurman RJ, Solomon D: The Bethesda System for reporting cervical\/vaginal cytologic diagnoses. New York; 1994."},{"key":"1121_CR35","first-page":"209","volume":"7","author":"MMT Manos","year":"1989","unstructured":"Manos MMT, Wright DK, Lewis AJ, Broker TR, Wolinsky SM: The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cell Mol Diagnost Hum Cancer 1989, 7: 209-214.","journal-title":"Cancer Cell Mol Diagnost Hum Cancer"},{"key":"1121_CR36","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1099\/0022-1317-76-4-1057","volume":"76","author":"AM de Roda Husman","year":"1995","unstructured":"de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ: The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995, 76: 1057-1062. 10.1099\/0022-1317-76-4-1057","journal-title":"J Gen Virol"},{"key":"1121_CR37","doi-asserted-by":"publisher","first-page":"861","DOI":"10.4238\/vol7-3X-Meeting04","volume":"7","author":"TD Otto","year":"2008","unstructured":"Otto TD, Vasconcellos EA, Gomes LH, Moreira AS, Degrave WM, Mendonca-Lima L, Alves-Ferreira M: ChromaPipe: a pipeline for analysis, quality control and management for a DNA sequencing facility. Genet Mol Res 2008, 7: 861-871. 10.4238\/vol7-3X-Meeting04","journal-title":"Genet Mol Res"},{"key":"1121_CR38","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/molbev\/msm092","volume":"24","author":"K Tamura","year":"2007","unstructured":"Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24: 1596-1599. 10.1093\/molbev\/msm092","journal-title":"Mol Biol Evol"},{"key":"1121_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","author":"EM de Villiers","year":"2004","unstructured":"de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology 2004, 324: 17-27. 10.1016\/j.virol.2004.03.033","journal-title":"Virology"},{"key":"1121_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1046\/j.1523-1747.1999.00641.x","volume":"113","author":"SJ Weissenborn","year":"1999","unstructured":"Weissenborn SJ, Hopfl R, Weber F, Smola H, Pfister HJ, Fuchs PG: High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. J Invest Dermatol 1999, 113: 122-126. 10.1046\/j.1523-1747.1999.00641.x","journal-title":"J Invest Dermatol"},{"key":"1121_CR41","first-page":"1394","volume":"11","author":"PE Castle","year":"2002","unstructured":"Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A: Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2002, 11: 1394-1399.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1121_CR42","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1128\/JCM.00824-08","volume":"46","author":"PE Castle","year":"2008","unstructured":"Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M: Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol 2008, 46: 2595-2604. 10.1128\/JCM.00824-08","journal-title":"J Clin Microbiol"},{"key":"1121_CR43","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1309\/XFUCPP6M5XUA94B8","volume":"120","author":"P de Cremoux","year":"2003","unstructured":"de Cremoux P, Coste J, Sastre-Garau X, Thioux M, Bouillac C, Labbe S, Cartier I, Ziol M, Dosda A, Le Gales C, et al.: Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology. Am J Clin Pathol 2003, 120: 492-499. 10.1309\/XFUCPP6M5XUA94B8","journal-title":"Am J Clin Pathol"},{"key":"1121_CR44","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1128\/JCM.00278-09","volume":"47","author":"M Poljak","year":"2009","unstructured":"Poljak M, Kocjan BJ, Kovanda A, Lunar MM, Lepej SZ, Planinic A, Seme K, Vince A: Human papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail. J Clin Microbiol 2009, 47: 2611-2615. 10.1128\/JCM.00278-09","journal-title":"J Clin Microbiol"},{"key":"1121_CR45","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1016\/S1386-6532(02)00187-7","volume":"25","author":"M Poljak","year":"2002","unstructured":"Poljak M, Marin IJ, Seme K, Vince A: Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 2002, 25: S89-97. 10.1016\/S1386-6532(02)00187-7","journal-title":"J Clin Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T06:36:49Z","timestamp":1630478209000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,5]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1121"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-4","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,5]]},"assertion":[{"value":"10 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}